ProShare Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.1K | Buy |
18,898
+50
| +0.3% | +$193 | ﹤0.01% | 1934 |
|
|
2025
Q1 | $94.2K | Sell |
18,848
-4,523
| -19% | -$22.6K | ﹤0.01% | 1844 |
|
|
2024
Q4 | $169K | Buy |
23,371
+9,950
| +74% | +$71.7K | ﹤0.01% | 1935 |
|
|
2024
Q3 | $82.4K | Buy |
+13,421
| New | +$82.4K | ﹤0.01% | 1912 |
|
|
2022
Q2 | – | Sell |
-11,650
| Closed | -$71K | – | 1800 |
|
|
2022
Q1 | $71K | Sell |
11,650
-3,627
| -24% | -$22.1K | ﹤0.01% | 2082 |
|
|
2021
Q4 | $139K | Buy |
15,277
+1,714
| +13% | +$15.6K | ﹤0.01% | 2143 |
|
|
2021
Q3 | $153K | Sell |
13,563
-1,757
| -11% | -$19.8K | ﹤0.01% | 1844 |
|
|
2021
Q2 | $151K | Buy |
+15,320
| New | +$151K | ﹤0.01% | 2214 |
|
|
2017
Q1 | – | Sell |
-33
| Closed | -$33K | – | 1565 |
|
|
2016
Q4 | $33K | Buy |
+33
| New | +$33K | ﹤0.01% | 1723 |
|